These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 27752985)
1. Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine. Lydecker AG; Sharma A; McCurdy CR; Avery BA; Babu KM; Boyer EW J Med Toxicol; 2016 Dec; 12(4):341-349. PubMed ID: 27752985 [TBL] [Abstract][Full Text] [Related]
2. LC-MS-MS method for mitragynine and 7-hydroxymitragynine in hair and its application in authentic hair samples of suspected kratom abusers. Rhee J; Shin I; Kim J; Lee J; Cho B; Kim J; Park M; Kim E J Anal Toxicol; 2024 Jul; 48(6):429-438. PubMed ID: 38780234 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry. Sharma A; Kamble SH; León F; Chear NJ; King TI; Berthold EC; Ramanathan S; McCurdy CR; Avery BA Drug Test Anal; 2019 Aug; 11(8):1162-1171. PubMed ID: 30997725 [TBL] [Abstract][Full Text] [Related]
4. A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products. Fowble KL; Musah RA Forensic Sci Int; 2019 Jun; 299():195-202. PubMed ID: 31059866 [TBL] [Abstract][Full Text] [Related]
5. Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions. Todd DA; Kellogg JJ; Wallace ED; Khin M; Flores-Bocanegra L; Tanna RS; McIntosh S; Raja HA; Graf TN; Hemby SE; Paine MF; Oberlies NH; Cech NB Sci Rep; 2020 Nov; 10(1):19158. PubMed ID: 33154449 [TBL] [Abstract][Full Text] [Related]
6. Beneficial and adverse health effects of kratom (Mitragyna speciosa): A critical review of the literature. Heywood J; Smallets S; Paustenbach D Food Chem Toxicol; 2024 Oct; 192():114913. PubMed ID: 39134135 [TBL] [Abstract][Full Text] [Related]
7. Rapid detection by direct analysis in real time-mass spectrometry (DART-MS) of psychoactive plant drugs of abuse: the case of Mitragyna speciosa aka "Kratom". Lesiak AD; Cody RB; Dane AJ; Musah RA Forensic Sci Int; 2014 Sep; 242():210-218. PubMed ID: 25086346 [TBL] [Abstract][Full Text] [Related]
8. Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance. Zhang M; Sharma A; León F; Avery B; Kjelgren R; McCurdy CR; Pearson BJ PLoS One; 2022; 17(4):e0259326. PubMed ID: 35472200 [TBL] [Abstract][Full Text] [Related]
9. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants. Wang M; Carrell EJ; Ali Z; Avula B; Avonto C; Parcher JF; Khan IA J Sep Sci; 2014 Jun; 37(12):1411-8. PubMed ID: 24659356 [TBL] [Abstract][Full Text] [Related]
10. Development, validation, and application of an LC-MS/MS method for mitragynine and 7-hydroxymitragynine analysis in hair. Meier U; Mercer-Chalmers-Bender K; Scheurer E; Dussy F Drug Test Anal; 2020 Feb; 12(2):280-284. PubMed ID: 31833662 [TBL] [Abstract][Full Text] [Related]
11. Kratom (Mitragyna speciosa) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products. Manwill PK; Flores-Bocanegra L; Khin M; Raja HA; Cech NB; Oberlies NH; Todd DA Planta Med; 2022 Aug; 88(9-10):838-857. PubMed ID: 35468648 [TBL] [Abstract][Full Text] [Related]
12. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users. Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368 [TBL] [Abstract][Full Text] [Related]
13. Determination of Alkaloids in Mudge EM; Brown PN J AOAC Int; 2018 Jul; 101(4):964-965. PubMed ID: 29678221 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of α-Glucosidase and Pancreatic Lipase Properties of Limcharoen T; Pouyfung P; Ngamdokmai N; Prasopthum A; Ahmad AR; Wisdawati W; Prugsakij W; Warinhomhoun S Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235558 [TBL] [Abstract][Full Text] [Related]
15. "Evaluation of ion mobility spectrometry for the detection of mitragynine in kratom products". Fuenffinger N; Ritchie M; Ruth A; Gryniewicz-Ruzicka C J Pharm Biomed Anal; 2017 Feb; 134():282-286. PubMed ID: 27951469 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats. Behnood-Rod A; Chellian R; Wilson R; Hiranita T; Sharma A; Leon F; McCurdy CR; McMahon LR; Bruijnzeel AW Drug Alcohol Depend; 2020 Oct; 215():108235. PubMed ID: 32889450 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats. Kamble SH; Berthold EC; King TI; Raju Kanumuri SR; Popa R; Herting JR; León F; Sharma A; McMahon LR; Avery BA; McCurdy CR J Nat Prod; 2021 Apr; 84(4):1104-1112. PubMed ID: 33620222 [TBL] [Abstract][Full Text] [Related]
18. Identification of metabolites and potential biomarkers of kratom in urine. Basiliere S; Kerrigan S J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():121971. PubMed ID: 32058315 [TBL] [Abstract][Full Text] [Related]
19. [Discrimination of Kratom Products by an Improved PCR-RFLP Method]. Ogata J; Kawamura M; Hakamatsuka T; Kikura-Hanajiri R Yakugaku Zasshi; 2020; 140(12):1501-1508. PubMed ID: 33268690 [TBL] [Abstract][Full Text] [Related]
20. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats. Avery BA; Boddu SP; Sharma A; Furr EB; Leon F; Cutler SJ; McCurdy CR Planta Med; 2019 Mar; 85(4):340-346. PubMed ID: 30452072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]